Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
Conditions: Lymphoma; Multiple Myeloma; Non-Hodgkin Lymphoma; Relapsed Hodgkin's Disease, Adult Intervention: Drug: Isatuximab Sponsors: Divaya Bhutani; Genzyme, a Sanofi Company Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Hodgkin's Disease | Lymphoma | Myeloma | Research | Stem Cell Therapy | Stem Cells | Transplants